Cargando…
PRRT of neuroendocrine tumors: individualized dosimetry or fixed dose scheme?
Great efforts have been made in dosimetry for individualizing PRRT. However, many centers do not use dosimetry and its results hardly influence treatment. A reason for that is that reliable thresholds for organs-at-risk, kidneys and bone marrow, and treatment response are lacking. The nuclear medici...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158965/ https://www.ncbi.nlm.nih.gov/pubmed/32296955 http://dx.doi.org/10.1186/s13550-020-00623-3 |